Stock ANAB ANAPTYSBIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart AnaptysBio, Inc.

Equities

ANAB

US0327241065

Real-time Estimate Cboe BZX
Other stock markets
 12:46:33 2024-05-21 pm EDT 		5-day change 1st Jan Change
24.8 USD -0.82% Intraday chart for AnaptysBio, Inc. -1.66% +15.97%
May. 09 AnaptysBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 09 Anaptys Announces Positive Top-Line Gemini-2 Phase 3 Clinical Trial Results of imsidolimab (IL-36R) in Generalized Pustular Psoriasis CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ANAPTYSBIO, INC. Stock AnaptysBio, Inc.
 683M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 22.31B -
ARGENX SE Stock argenx SE
 21.6B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 18.23B -
  1. Stock Market
  2. Equities
  3. ANAB Stock
  4. Charts AnaptysBio, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW